基本信息
浏览量:10
职业迁徙
个人简介
Dr. Hostetler is the co-inventor of Antiva Biosciences’ intellectual property with two UCSD scientists. Dr. Hostetler was previously a founder and served on the Boards of Directors of three biopharmaceutical companies: Vical, Inc. (VICL), Triangle Pharmaceuticals (VIRS, acquired by Gilead Sciences), and Chimerix Inc. (CMRX). He retired from Chimerix in 2012 to found Hera Therapeutics, Inc., now Antiva Biosciences, Inc. In 2012 Dr. Hostetler was the recipient of the Gertrude Elion Memorial Award from the International Society for Antiviral Research for his work in antiviral drug design. He has authored or co- authored over 200 scientific publications and is an inventor on 66 issued US Patents. Dr. Hostetler holds an M.D. degree from Western Reserve University and is currently an Active Emeritus Professor of Medicine in the Division of Infectious Disease at UCSD.
研究兴趣
论文共 237 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Antiviral research (2023): 105718-105718
Journal of medicinal chemistryno. 8 (2023): 5802-5819
bioRxiv (Cold Spring Harbor Laboratory) (2021)
MICROBIOLOGY SPECTRUMno. 3 (2021): e0153721-e0153721
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn